tiprankstipranks
Atossa Therapeutics (ATOS)
NASDAQ:ATOS

Atossa Therapeutics (ATOS) Technical Analysis

2,045 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Atossa Therapeutics’s (ATOS) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Atossa Therapeutics is a Sell.
Atossa Therapeutics’s (ATOS) 20-Day exponential moving average is 1.27, while Atossa Therapeutics’s (ATOS) share price is $1.34, making it a Buy.
Atossa Therapeutics’s (ATOS) 50-Day exponential moving average is 1.30, while Atossa Therapeutics’s (ATOS) share price is $1.34, making it a Buy.

Atossa Therapeutics (ATOS) Pivot Points

Jul 22, 2024, 06:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.22
1.28
1.32
1.37
1.41
1.47
1.51
Fibonacci
1.28
1.31
1.34
1.37
1.41
1.43
1.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Atossa Therapeutics (ATOS) Moving Averages

Jul 22, 2024, 06:10 AM
Period
Simple
Exponential
MA5
1.38Sell
1.35Sell
MA10
1.30Buy
1.31Buy
MA20
1.21Buy
1.27Buy
MA50
1.32Buy
1.30Buy
MA100
1.41Sell
1.29Buy
MA200
1.10Buy
1.12Buy
Atossa Therapeutics’s (ATOS) 10-Day exponential moving average is 1.31, while Atossa Therapeutics’s (ATOS) share price is $1.34, making it a Buy.
Atossa Therapeutics’s (ATOS) 100-Day exponential moving average is 1.29, while Atossa Therapeutics’s (ATOS) share price is $1.34, making it a Buy.
Atossa Therapeutics’s (ATOS) stock price is $1.34 and Atossa Therapeutics’s (ATOS) 50-day simple moving average is 1.32, creating a Buy signal.
Atossa Therapeutics’s (ATOS) stock price is $1.34 and Atossa Therapeutics’s (ATOS) 100-day simple moving average is 1.41, creating a Sell signal.
Atossa Therapeutics’s (ATOS) stock price is $1.34 and Atossa Therapeutics’s (ATOS) 200-day simple moving average is 1.10, creating a Buy signal.

Atossa Therapeutics (ATOS) Technical Indicators

Jul 22, 2024, 06:10 AM
Name
Value
Implied Action
RSI (14)
57.14
Neutral
STOCH (9,6)
78.69
Neutral
STOCHRSI (14)
80.61
Sell
MACD (12,26)
0.03
Sell
ADX (14)
24.34
Neutral
Williams %R
-26.47
Buy
CCI (14)
94.27
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
59.51
Neutral
ROC
12.61
Buy
Atossa Therapeutics’s (ATOS) Relative Strength Index (RSI) is 57.14, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Trend Strength Indicator (ADX) is 24.34, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Commodity Channel Index (CCI) is 94.27, creating a Neutral signal.
Atossa Therapeutics’s (ATOS) Price Rate of Change (ROC) is 12.61, creating a Buy signal.

FAQ

Is ATOS a Buy, Hold, or Sell?
Based on ATOS’s technical indicators, ATOS is a Buy.
    What is ATOS’s RSI (14)?
    ATOS’s RSI (14) is 57.14, which suggests ATOS is a Neutral.
      What is ATOS’s MACD?
      ATOS’s MACD is 0.03, which suggests ATOS is a Sell.
        What is ATOS’s 5-day moving average?
        ATOS’s 5-day moving average is 1.38, which suggests ATOS is a Sell.
          What is ATOS’s 20-day moving average?
          ATOS 20-day moving average is 1.21, which suggests ATOS is a Buy.
            What is ATOS’s 50-day moving average?
            ATOS’s 50-day moving average is 1.32, which suggests ATOS is a Buy.
              What is ATOS’s 200-day moving average?
              ATOS’s 200-day moving average is 1.10, which suggests ATOS is a Buy.
                What is ATOS’s Williams % R (14)?
                ATOS’s Williams % R (14) is -26.47, which suggests ATOS is a Buy.
                  What is ATOS’s CCI (14)?
                  ATOS’s CCI (14) is 94.27, which suggests ATOS is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis